Immune Signatures May Predict Adverse Events in Patients Taking Immunotherapy | Naviance

Immune Signatures May Predict Adverse Events in Patients Taking Immunotherapy

Immune Signatures May Predict Adverse Events in Patients Taking Immunotherapy

A study by researchers from the Centro Oncológico Johns Hopkins Kimmel y su Bloomberg~Instituto Kimmel de Inmunoterapia contra el Cáncer have identified distinct immune “signatures” in patients who develop adverse events while taking immunotherapy for cancer. This may help oncologists identify patients at serious risk for immunotherapy-related side effects.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers How Hypoxia Helps Cancer Spread Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models Johns Hopkins Joins Cancer AI Alliance AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer A Common Culprit Drives Prostate Cancer Progression